Research suggests elevated levels of the protein GLI1 (glioma-associated oncogene homolog 1) may point to more aggressive and advanced breast cancer tumors, reports HealthDay.
German researchers compared healthy breast tissue with 229 breast tissue samples taken from breast cancer patients. Greater likelihood of death, advanced cancer and an increased number of cancerous lymph nodes were found in patients with elevated levels of the GLI1 protein, according to the study.
Researchers say the study's findings, which were published in the journal BMC Cancer, may help doctors determine a patient's prognosis.
Discuss this post and share your personal experiences at the CancerCompass Breast Cancer Message Board.